Pacira Biosciences Inc (PCRX)

Cost of Revenue

$155.15M

TTM · Period ending: · USD

PCRX logo

PCRX Cost of Revenue

Latest reported$155.15M
PCRX TTM Cost of Revenue ($12.28M → $155.15M)
High-resolution chart · PNG

PCRX cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pacira Biosciences Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
155,154,000
151,856,000
149,749,000
149,336,000
153,922,000
157,318,000
170,428,000
178,234,000
179,120,000
183,065,000
184,669,000
198,893,000
209,821,000
212,241,000
199,295,000
176,386,000
160,359,000
144,980,000
140,255,000
136,545,000
131,887,000
118,944,000
117,327,000
113,933,000
106,244,000
109,140,000
106,711,000
98,787,000
95,548,000
91,263,000
86,845,000
84,161,000
83,324,000
86,219,000
87,915,000
90,241,000
115,165,000
114,407,000
110,104,000
105,910,000
78,659,000
74,535,000
71,837,000
71,378,000
75,868,000
76,893,000
77,440,000
76,848,000
71,248,000
61,508,000
54,772,000
46,068,000
40,564,000
37,035,000
32,139,000
29,068,000
23,138,000
19,568,000
16,740,000
12,247,000
12,463,000
12,197,000
12,276,000
13,646,000
12,792,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.